Skip to content
Super promo!Reishi−50%59.50 zł119 zł (regular price)
Only 28 left at 59.50 zł, then 71.40 złSee Reishi →
Free delivery in Poland from 299 PLN

Reishi extract: what 10:1 means, beta-glucans, and how to read the label

DER 10:1, standardization to beta-glucans via the Megazyme method, dual extraction. We break down a reishi extract label point by point, before you buy.

Mateusz Rosa

TCM therapist · Doctor of Acupuncture (WFAS) · author of a book on functional mushrooms

6 min read

Reishi extract: what 10:1 means, beta-glucans, and how to read the label
Contents

You're buying a reishi mushroom extract and the label says "10:1" and "min. 30% beta-glucans", but nobody has explained what those numbers actually tell you about what's in the package. This post breaks down the reishi label into four questions worth asking before you buy, and shows what they look like in practice on our own raw material.

What is reishi extract, and how is it different from fruiting-body powder?

Reishi extract is a concentrated form of the fruiting body, with part of the inactive mass (fiber, water) removed, leaving the compounds soluble in water and alcohol. Plain dried fruiting-body powder contains the same compounds, but at the dilution natural to the raw material, without a concentration step.

The difference is practical, not marketing. Powdered reishi fruiting body is the whole, ground mushroom, with everything in it, including mass your body can't digest. Extract is the result of a process that pulls out and concentrates the soluble fraction from the same amount of raw material. That's why our LONGEVITY line blends both forms in equal parts (50% 10:1 extract and 50% powdered fruiting body), while our PRIME line shifts the ratio toward extract (80% to 20%), so you can choose the intensity.

What does 10:1 (DER) mean?

DER, or drug-extract ratio, is the proportion of raw material used to produce one unit of finished extract. At DER 10:1, the producer uses 10 kilograms of dried reishi fruiting body to get 1 kilogram of extract, a tenfold concentration relative to the starting material.

The DER number alone says nothing about the quality of the fruiting body or the extraction method, so it's always worth pairing it with a second number: standardization to a specific compound. Our 10:1 extract comes from Ganoderma lucidum fruiting bodies grown in semi-wild cultivation, not from mycelium grown on grain, which matters for the ratio of compounds we cover below.

What are beta-glucans and "min. 30% via the Megazyme method"?

Beta-glucans are a group of polysaccharides built from glucose molecules, present in the cell wall of the reishi fruiting body and many other mushrooms. The Megazyme method is a standardized, enzymatic laboratory procedure for measuring beta-glucan content, widely regarded in the industry as more reliable than simplified colorimetric tests.

Our 10:1 extract is standardized to a minimum of 30% beta-glucans measured with this exact method. In practice, in a daily serving of our PRIME line (3 capsules of 450 mg, i.e. 1.35 g), 1080 mg is extract, of which a minimum of 324 mg is beta-glucans, with the remaining 270 mg coming from powdered fruiting body. That's a concrete number on the label, not a vague "rich in polysaccharides" claim.

Why dual water-alcohol extraction?

Dual water-alcohol extraction combines two steps, because different groups of compounds in the reishi fruiting body dissolve in different solvents. A single process doesn't pull out everything of chemical value from the mushroom.

The water fraction pulls out mainly polysaccharides, including beta-glucans, while the alcohol fraction pulls out triterpenes, which include ganoderic acids, compounds not soluble in water alone. Producers who run only one extraction (usually water, since it's cheaper) leave the whole triterpene fraction in the waste stream. Two steps mean a longer and more expensive production process, but they yield an extract closer to the fruiting body's full compound profile.

How to read a reishi label in 5 points

Before you buy a reishi mushroom extract, check five specific things on the label, rather than going by brand name or price per package alone. Each of these points gives you a different piece of the picture.

  • Fruiting body vs. mycelium on grain · fruiting body is the hard, visible part of the mushroom known from tradition; mycelium on grain is a cheaper cultivation substrate with a different compound ratio.
  • DER (extraction ratio) · e.g. 10:1, tells you about concentration, not raw material quality.
  • Beta-glucan percentage and measurement method · a percentage without a stated method (e.g. Megazyme) is hard to verify.
  • Milligrams per serving, not just percentage · a percentage in the extract is not the same as the real amount in a daily capsule or scoop.
  • Batch testing · does the producer test every batch at an independent, accredited laboratory for heavy metals and pesticides.

In our case, every batch goes to the independent, accredited Eurofins laboratory before a package leaves the warehouse.

Frequently asked questions about reishi extract

Does a higher DER always mean a better product? Not automatically. A higher DER tells you about weight-based concentration, not the content of specific compounds. A 4:1 extract standardized to a high beta-glucan percentage can realistically contain more per serving than a non-standardized 15:1 extract. Always look at both parameters together.

How is a beta-glucan different from the general term "polysaccharide"? A beta-glucan is one specific group of polysaccharides, built from linked glucose molecules. "Polysaccharide" is a broader category covering many different compounds, so a label with just the word "polysaccharides" tells you less than a label with a concrete beta-glucan percentage.

Why are some reishi extracts cheaper despite a similar DER? Most often because they skip one of the extraction steps (water only instead of water and alcohol), use mycelium on grain instead of fruiting body, or don't test every batch at an independent laboratory. These choices lower production cost, but they also change the composition of the final product.

Does the label always state the beta-glucan measurement method? Not always, and that's a warning sign. A percentage without a stated method (e.g. Megazyme, spectrophotometric) is hard to verify and compare across products from different producers.

For more on choosing between reishi forms in practice, see our post on capsules, powder, and drops, and for dosage in concrete numbers see reishi dosage. We've gathered answers to other questions about the species in reishi FAQ, and we cover the mechanisms of the compounds in How reishi works.


This content is for educational purposes only and does not constitute medical advice. A food supplement does not replace a varied diet or a healthy lifestyle. If in doubt, consult your doctor or pharmacist.

Reishi in scientific research

What was studied, on how many people and with what level of evidence. This overview describes studies, not the effects of a product.

8

human studies

3

placebo-controlled RCTs

2005–2025

years of publication

  • Jin X. et al., 2016

    A

    Cochrane systematic review with meta-analysis

    5 RCTs, total number of people not reported

    The review collected randomised studies on the use of Ganoderma lucidum in the context of oncological treatment. The authors noted unsatisfactory methodological quality of the primary studies, incomplete outcome reporting, no long-term survival data, and adverse events reported in only one study.

    PMID 27045603
  • Klupp N.L. et al., 2015

    A

    Cochrane systematic review with meta-analysis

    5 studies, 398 people

    The review collected randomised studies on the effect of Ganoderma lucidum on cardiovascular risk factors in people with type 2 diabetes. The authors noted that only 3 of 5 studies provided data suitable for statistical analysis.

    PMID 25686270
  • Jafari A. et al., 2025

    B

    systematic review with meta-analysis, GRADE assessment

    17 RCTs, 971 people

    The review collected clinical trials on Ganoderma lucidum supplementation regarding anthropometric, metabolic, inflammatory and liver markers. GRADE-assessed evidence quality was very low for all analysed outcomes.

    PMID 40510787
  • Zhong L. et al., 2019

    B

    systematic review with meta-analysis of RCTs

    23 studies, 4246 people

    The review collected randomised studies on Coriolus versicolor and Ganoderma lucidum preparations used as adjunct therapy in oncology patients. Studies were conducted almost exclusively in Asia, with heterogeneous preparations and doses.

    PMID 31333449
  • Klupp N.L. et al., 2016

    C

    RCT, double-blind, placebo-controlled

    84 people

    The study examined the effect of Ganoderma lucidum, alone and combined with Cordyceps sinensis, on glycaemic parameters and other cardiovascular risk factors in 84 people with type 2 diabetes and metabolic syndrome. Observation period limited to 16 weeks.

    PMID 27511742
  • Noguchi M. et al., 2008

    C

    RCT

    88 men over 49 years old

    The study examined the effect of an ethanol extract of Ganoderma lucidum on lower urinary tract symptoms in 88 men over 49 years old. The authors recommended further evaluation on a larger sample and over a longer period.

    PMID 18097505
  • Aref M. et al., 2023

    E

    meta-analysis of animal studies · preclinical studies (in vitro and rodent)

    not applicable, 49 papers

    The review collected animal studies on the effect of Ganoderma lucidum on serum lipid profile. Dose variation between studies, scope limited to animal models.

    PMID 38116485
  • Tang W. et al., 2005

    C

    RCT, double-blind, placebo-controlled

    132 people (China)

    The study examined the effect of 8 weeks of taking a Ganoderma lucidum polysaccharide extract on a neurasthenia symptom severity scale score in 132 Chinese patients. Limitations were not stated explicitly in the abstract.

    PMID 15857210
  • Cui X.Y. et al., 2012

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined the effect of a 3-day Ganoderma lucidum extract administration (80 mg/kg) on total sleep time and NREM sleep, and on TNF-α levels in blood and brain, using TNF-α blocking antibodies to test the mechanism.

    PMID 22207209
  • Chu Q.P. et al., 2007

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined the effect of an aqueous extract (80 and 120 mg/kg) on sleep architecture in healthy animals and on pentobarbital-induced sleep, using flumazenil to test the GABAergic mechanism.

    PMID 17383716
  • Wang X. et al., 2025

    C

    RCT, double-blind, placebo-controlled

    110 randomised (55/group in final analysis), 12 weeks

    The study examined the effect of 12 weeks of Ganoderma lucidum spore oil supplementation (3 g daily, approx. 1 g triterpenes) on lipid profile and kidney/liver safety in people with borderline elevated triglycerides. Limited to a population with borderline hypertriglyceridemia and a short 12-week observation period.

    PMID 40077714

Evidence levels: A · Cochrane review · B · systematic review · C · placebo RCT · D · pilot RCT · E · preclinical studies

What these studies don't say

  • Samples are usually small, most from a single population.
  • Results describe research interventions, not a dietary supplement.
  • The presence of a study is not a health claim.

Source: Aloha Fungi literature review, 1 September 2026; entries verified via PubMed or by DOI (Crossref). See the research

Discover functional mushrooms

© 2026 Aloha Fungi™